| Product Code: ETC7623324 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Antithrombotic Drugs Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Antithrombotic Drugs Market - Industry Life Cycle |
3.4 Ireland Antithrombotic Drugs Market - Porter's Five Forces |
3.5 Ireland Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Ireland Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Ireland Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Ireland Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Ireland Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Ireland |
4.2.2 Growing awareness about the importance of antithrombotic drugs in preventing blood clots and related conditions |
4.2.3 Technological advancements leading to the development of more effective antithrombotic drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of antithrombotic drugs in Ireland |
4.3.2 High costs associated with research, development, and manufacturing of antithrombotic drugs |
4.3.3 Concerns regarding potential side effects and risks associated with long-term use of antithrombotic drugs |
5 Ireland Antithrombotic Drugs Market Trends |
6 Ireland Antithrombotic Drugs Market, By Types |
6.1 Ireland Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 Ireland Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 Ireland Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 Ireland Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 Ireland Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 Ireland Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 Ireland Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Ireland Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 Ireland Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 Ireland Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 Ireland Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Ireland Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 Ireland Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Ireland Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 Ireland Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 Ireland Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Ireland Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Ireland Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Ireland Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Ireland Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Ireland Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Ireland Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Ireland Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Ireland Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Ireland Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Ireland Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Ireland Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Ireland Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 Ireland Antithrombotic Drugs Market Export to Major Countries |
7.2 Ireland Antithrombotic Drugs Market Imports from Major Countries |
8 Ireland Antithrombotic Drugs Market Key Performance Indicators |
8.1 Patient adherence rates to antithrombotic drug treatment plans |
8.2 Number of new antithrombotic drug approvals by regulatory authorities in Ireland |
8.3 Rate of adoption of novel antithrombotic drug therapies in clinical practice |
9 Ireland Antithrombotic Drugs Market - Opportunity Assessment |
9.1 Ireland Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Ireland Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Ireland Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Ireland Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Ireland Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Antithrombotic Drugs Market - Competitive Landscape |
10.1 Ireland Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Ireland Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here